A novel haplotype in ABCA1 gene effects plasma HDL-C concentration

International Journal of Cardiology

Volumn 115, Issue 1, 2007, Pages 7-13

  Saleheen, Danish ^a   Khanum, Shaheen ^a   Haider, Shajjia R ^a   Nazir, Aisha ^a   Ahmad, Usman ^a   Khalid, Hamza ^a   Hussain, Imad ^a   Shuja, Fahad ^a   Shahid, Kamran ^a   Habib, Aisha ^b   Frossard, Philippe M ^a  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

ABCA1; Coronary artery disease; High density lipoprotein cholesterol; Low density lipoprotein cholesterol; Single nucleotide polymorphism

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENE SEQUENCE; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; HYPOLIPOPROTEINEMIA; INFORMED CONSENT; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PLEIOTROPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH ASIA; STROKE;

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL, HDL; FEMALE; HAPLOTYPES; HUMANS; HYPOALPHALIPOPROTEINEMIAS; MALE; MIDDLE AGED; PAKISTAN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33845198109     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.12.020     Document Type: Article

References (36)

1. Abbott R.D., Wilson P.W., Kannel W.B., and Castelli W.P. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 8 3 (1988 (May-Jun)) 207-211
2. Miller M., Mead L.A., Kwiterovich Jr. P.O., and Pearson T.A. Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease. Am J Cardiol 65 1 (1990 (Jan 1)) 1-5
3. Miller M., Seidler A., Kwiterovich P.O., and Pearson T.A. Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol. Circulation 86 4 (1992 (Oct)) 1165-1170
4. Attie A.D., Kastelein J.P., and Hayden M.R. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res 42 11 (2001 (Nov)) 1717-1726
5. Cockerill G.W., Huehns T.Y., Weerasinghe A., et al. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 103 1 (2001 (Jan 2)) 108-112
6. Dimayuga P., Zhu J., Oguchi S., et al. Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice. Biochem Biophys Res Commun 264 2 (1999 (Oct 22)) 465-468
7. Nofer J.R., Levkau B., Wolinska I., et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 276 37 (2001 (Sep 14)) 34480-34485
8. Nofer J.R., Kehrel B., Fobker M., Levkau B., Assmann G., and von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161 1 (2002 (Mar)) 1-16
9. Navab M., Hama S.Y., Anantharamaiah G.M., et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res 41 9 (2000 (Sep)) 1495-1508
10. Navab M., Hama S.Y., Hough G.P., et al. High density associated enzymes: their role in vascular biology. Curr Opin Lipidol 9 5 (1998 (Oct)) 449-456
11. Prenger V.L., Beaty T.H., and Kwiterovich P.O. Genetic determination of high-density lipoprotein-cholesterol and apolipoprotein A-1 plasma levels in a family study of cardiac catheterization patients. Am J Hum Genet 51 5 (1992 (Nov)) 1047-1057
12. Friedlander Y., Kark J.D., and Stein Y. Biological and environmental sources of variation in plasma lipids and lipoproteins: the Jerusalem Lipid Research Clinic. Hum Hered 36 3 (1986) 143-153
13. Bucher K.D., Friedlander Y., Kaplan E.B., et al. Biological and cultural sources of familial resemblance in plasma lipids: a comparison between North America and Israel-the Lipid Research Clinics Program. Genet Epidemiol 5 1 (1988) 17-33
14. Hunt S.C., Hasstedt S.J., Kuida H., Stults B.M., Hopkins P.N., and Williams R.R. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol 129 3 (1989 (Mar)) 625-638
15. Tall A.R., Breslow J.L., and Rubin E.M. Genetic disorders affecting plasma high-density lipoproteins. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease. 8th edition (2001), McGraw-Hill, New York, NY, USA 2915-2936
16. Bodzioch M., Orso E., Klucken J., et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22 4 (1999) 347-351
17. Klein I., Sarkadi B., and Varadi A. An inventory of the human ABC proteins. Biochim Biophys Acta 1461 2 (1999) 237-262
18. Schmitz G., and Langmann T. Structure, function and regulation of the ABC1 gene product. Curr Opin Lipidol 12 2 (2001) 129-140
19. Langmann T., Klucken J., Reil M., et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 257 1 (1999) 29-33
20. Bisoendial R.J., Hovingh G.K., Levels J.H., et al. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 107 23 (2003) 2944-2948
21. Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., and Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114 9 (2004 (Nov)) 1343-1353
22. Cohen J.C., Kiss R.S., Pertsemlidis A., Marcel Y.L., McPherson R., and Hobbs H.H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 5685 (2004 (Aug 6)) 869-872
23. Clee S.M., Zwinderman A.H., Engert J.C., et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103 9 (2001 (Mar 6)) 1198-1205
24. Singh Rb., and Niaz M.A. Coronary heart disease in Indians, Pakistanis and Bangladeshis: aetiology and possibilities for prevention. Br Heart J 69 (1993) 572
25. Saleheen D., Nazir A., Khanum S., Haider S.R., and Frossard P.M. R1615P: a novel mutation in ABCA1 associated with low levels of HDL and type II diabetes mellitus. Int J Cardiol (2005 (July 28))
26. Lapicka-Bodzioch K., Bodzioch M., Krull M., et al. Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome. Biochim Biophys Acta 1537 1 (2001) 42-48
27. Tregouet D.A., Barbaux S., Escolano S., et al. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 11 17 (2002) 2015-2023
28. Singaraja R.R., Brunham L.R., Visscher H., Kastelein J.J., and Hayden M.R. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23 8 (2003 (Aug 1)) 1322-1332
29. Drysdale C.M., McGraw D.W., Stack C.B., et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97 19 (2000) 10483-10488
30. Costet P., Luo Y., Wang N., and Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275 36 (2000) 28240-28245
31. Chinetti G., Lestavel S., Bocher V., et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7 1 (2001) 53-58
32. Joseph S.B., McKilligin E., Pei L., et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 99 11 (2002) 7604-7609
33. Miao B., Zondlo S., Gibbs S., et al. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J Lipid Res 45 8 (2004) 1410-1417
34. Schaefer E.J., Lamon-Fava S., Ordovas J.M., et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 35 5 (1994) 871-882
35. Stone N.J. Secondary causes of hyperlipidemia. Med Clin North Am 78 1 (1994) 117-141
36. Clee S.M., Zwinderman A.H., Engert J.C., et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103 9 (2001) 1198-1205